Neglected tropical diseases

What do we do

The Department of Control of Neglected Tropical Diseases coordinates and supports policies and strategies to enhance global access to interventions for the prevention, control, elimination and eradication of neglected tropical diseases, including some zoonotic diseases.

Consistent with World Health Assembly resolutions and in line with the WHO NTD Roadmap, we support Member States to expand access to prevention, diagnosis, treatment and care interventions for all those in need.

Why we work

Neglected tropical diseases cause immense human suffering and death. They pose a devastating obstacle to health and remain a serious impediment to poverty reduction and socioeconomic development.

How we improve access to health

Universal coverage against neglected tropical diseases depends to a large extent on enhanced access to free essential medicines and on stronger, well-planned, financially sound and efficient health systems.

We aim to prioritize the public health needs of poor and marginalized populations and provide technical and strategic guidance in key areas; coordinate the distribution of donated medicines; promote WHO’s role in partnership involvement; strengthen capacity country level capacity; and, leverage the contribution of stakeholders to the elimination and eradication of these diseases.

We deliver interventions through appropriate technology at sustainable cost and with the help of international partners, we support Member States in the coordination and integration of national control programmes with sectors such as education, agriculture and veterinary public health.

Follow us on Social Media


World Rabies Day 2015
(Facebook) | Archives

News highlights

22 September 2015 | Geneva
Kala-azar elimination programme. Report of a WHO consultation of partners. Geneva, Switzerland, 10–11 February 2015

18 September 2015 | Geneva
Global programme to eliminate lymphatic filariasis: progress report, 2014
Weekly epidemiological record, No.38, 2015, 90, 489–504

27 August 2015 | Geneva
WHO and Novartis extend agreement to treat millions of leprosy patients with free medicines